RB homepage

chess-1215079_1920.jpg

The man purportedly became addicted to board games during the height of the pandemic. This led him to purchasing “excessive quantities," putting him thousands of dollars in debt. 

cvi42 | Plaque from Circle Cardiovascular Imaging

Circle Cardiovascular Imaging, a Canadian medtech company, received the key approval for its cvi42 | Plaque platform.

Currently, chronic traumatic encephalopathy can only be diagnosed post-mortem via brain tissue assessment during an autopsy.

Closed

A news release indicates the suspensions are due to breast images not meeting the college's clinical quality standards. 

closing closure going out of business shutter

Radiologists who experienced a practice closure are more likely to operate as subspecialists afterward, according to new Neiman research.  

Philips Headquarters

Meanwhile, the Amsterdam-based imaging giant said it has already taken action to begin correcting these issues. 

Innovation at work

Six years ago, two radiologists with dissimilar backgrounds and divergent clinical interests put their heads together and launched a new practice. One physician was an academic subspecialized in musculoskeletal reads. The other, a private practitioner, concentrated on oncologic imaging. That’s how Transparent Imaging was born, powered by Konica Minolta. 

Sponsored by Konica Minolta

In a private dining room in Miami, something unusual is happening. Leaders from competing imaging centers are openly discussing their best practices—even sharing vendor recommendations and operational strategies that have doubled their volumes while cutting costs in half.

In cooperation with AbbaDox

Around the web

A growing number of private insurers are now covering these advanced technologies. Roosha Parikh, MD, told Cardiovascular Business that the hard work of SCCT and other groups has helped make this happen. 

Customers are urged to stop using these devices right away.

Researchers used AI-enabled software developed by Cleerly to evaluate the CCTA results of more than 6,000 patients. The software was consistently effective, identifying patients who may face an increased risk of poor outcomes.